Compound information
- Natural Products
- ZC3365920
- Molecular Formula
- C29H26N2O3
- Molecular Weight
- 450.194342692 g/mol
- Structure
-
- IUPAC Name
- benzyl N-[(1S)-1-benzyl-2-oxo-2-(4-phenylanilino)ethyl]carbamate
- InChI
- InChI=1S/C29H26N2O3/c32-28(30-26-18-16-25(17-19-26)24-14-8-3-9-15-24)27(20-22-10-4-1-5-11-22)31-29(33)34-21-23-12-6-2-7-13-23/h1-19,27H,20-21H2,(H,30,32)(H,31,33)/t27-/m0/s1
- InChI Key
- WJJSNYGLHKFYNL-MHZLTWQESA-N
- SMILES
- O=C(N[C@@H](Cc1ccccc1)C(=O)Nc1ccc(-c2ccccc2)cc1)OCc1ccccc1
- Source
- ZINC000409004042
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 34 | Ring Count | 4 |
Heteroatom Count | 5 | Rotatable Bond Count | 8 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 67.43 Å2 | LogP | 5.789 |
LogS | -7.359 | LogD | 4.31 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.058 | Pgp substrate | 0.185 |
HIA | 0.963 | F20 % | 0.982 |
F30 % | 0.159 | Caco-2 | -4.81 |
MDCK | -4.566 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.0 | PPB | 97.63 |
VD | 0.495 | Fu | 2.533 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.794 | CYP1A2 substrate | 0.732 |
CYP2A6 substrate | 0.355 | CYP2B6 substrate | 0.677 |
CYP2C19 inhibitor | 0.939 | CYP2C19 substrate | 0.912 |
CYP2C8 substrate | 0.888 | CYP2C9 inhibitor | 0.833 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.07 |
CYP2D6 substrate | 0.931 | CYP2E1 substrate | 0.305 |
CYP3A4 inhibitor | 0.259 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.273 | CL | 6.755 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.396 | Hepatotoxicity | 1.0 |
Mutagenicity | 0.321 | Rat Oral Acute Toxicity | 0.071 |
FDAMDD | 0.292 | Skin Sensitization | 0.376 |
Carcinogenicity | 0.974 | Eye Corrosion | 0.008 |
Eye Irritation | 0.03 | Respiratory Toxicity | 0.05 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 1.048 | IGC50 | 5.779 |
LC50FM | 5.295 | LC50DM | 6.387 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.47 | NR-AR-LBD | 0.217 |
NR-AhR | 0.869 | NR-Aromatase | 0.67 |
NR-ER | 0.906 | NR-ER-LBD | 0.612 |
NR-PPAR-gamma | 0.86 | SR-ARE | 0.815 |
SR-ATAD5 | 0.834 | SR-HSE | 0.573 |
SR-MMP | 0.864 | SR-p53 | 0.72 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.